Search
Heart stents row: Can’t stop companies from exiting due to price caps
April 27, 2017
- Are prices of medical stents high because it costs a lot to produce them, or it is because commissions are paid to everyone involved in the heart operation, from the hospital to the doctors and more?
- The answers will vary depending on whom you speak to.
- Even though an IMS Health study had, last year, pointed to prices falling 30-50% over the previous four years while angioplasty prices had not fallen, it is not surprising the government should choose to put a cap on the prices of stents.
- Given how drug price control has, in the past, led to a situation in which DPCO drugs production has either contracted or not grown as fast as non-DPCO drugs.
